IDiyas

For the Inventor, By the Inventor

Frankfurt am Main, Germany

Stefan Theis

USPTO Granted Patents = 6


 

Average Co-Inventor Count = 5.9

ph-index = 5

Forward Citations = 197(Granted Patents)


Company Filing History:

goldMedal6 out of 1,827 
 
Sanofi-a Ventis Deutschland Gmbh
 patents

Years Active: 2009-2012

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents
1. 8106023 - 1,4-benzothiepin-1, 1-dioxide derivatives with improved properties method for producing the same, drugs containing said compounds and the use thereof (2012-01-31),
2. 8101583 - 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with fluorine, method for producing the same, drugs containing said compounds and use thereof (2012-01-24),
3. 7956085 - 1,4-benzothiepine 1,1-dioxide derivatives substituted by benzyl radicals, method for their preparation, pharmaceuticals comprising these compounds, and the use thereof (2011-06-07),
4. 7923468 - 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with cyclohexyl groups, method for producing the same, drugs containing said compounds and use thereof (2011-04-12),
5. 7820804 - Fluoroglycoside derivatives of pyrazoles, medicaments containing these compounds, and the use thereof (2010-10-26),
6. 7615536 - 1,4-benzothiazepine 1,1-dioxide derivative, process for its preparation, medicaments comprising this compound, and use thereof as a hypolipidaemic (2009-11-10),

Title: The Innovations of Stefan Theis

Introduction

Stefan Theis is a notable inventor based in Frankfurt am Main, Germany. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on 1,4-benzothiepin-1,1-dioxide derivatives. With a total of 6 patents to his name, his inventions are paving the way for advancements in drug development.

Latest Patents

Stefan Theis's latest patents include groundbreaking work on novel 1,4-benzothiepin-1,1-dioxide derivatives with improved properties. His first patent details a method for producing these compounds, along with the drugs containing said compounds and their uses. The second patent focuses on 1,4-benzothiepin-1,1-dioxide derivatives that are substituted with fluorine, again detailing the method for production, the drugs containing these compounds, and their applications.

Career Highlights

Stefan Theis is currently employed at Sanofi-Aventis Deutschland GmbH, where he continues to innovate and contribute to the pharmaceutical industry. His work is characterized by a commitment to improving drug efficacy and safety through novel chemical compounds.

Collaborations

Stefan collaborates with esteemed colleagues such as Heiner Glombik and Hubert Heuer, enhancing the research and development efforts within his team.

Conclusion

Stefan Theis exemplifies the spirit of innovation in the pharmaceutical field, with his patents reflecting a dedication to improving healthcare through advanced drug development. His contributions are significant and continue to influence the industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…